JUPITER NEUROSCIENCES, INC. 8K

Jupiter Neurosciences, Inc. approved and executed a 1-for-75 reverse stock split of its common stock effective August 6, 2026, through an amendment to its Certificate of Incorporation.

Jupiter Neurosciences, Inc. amended its Certificate of Incorporation under Delaware law to implement a 1-for-75 reverse stock split of its common stock, effective at 4:01 p.m. Eastern Time on August 6, 2026, under which every seventy-five shares of common stock issued, outstanding, or held in treasury will be automatically combined into one share, fractional shares will not be issued and will instead be handled in accordance with Section 155 of the DGCL, and the rights, preferences, and privileges of the common and preferred stock will be adjusted accordingly, with all other provisions of the Certificate of Incorporation remaining in effect; the amendment was duly adopted pursuant to Section 242 of the DGCL and executed by Chairman and CEO Christer Rosén on August 6, 2026.

Filing Facts

CIK

1679628

Ticker

-

Form

8K

Source Type

sec

Accession

0001493152-26-036279

Alert Tier

6